HairDx Opens European Subsidiary | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular dermatology company HairDx, a subsidiary of PharmaGenoma, has launched a Belgian subsidiary to market its hair loss predictive test products in Europe, the company said today.

PharmaGenoma said that the HairDx Europe subsidiary will offer throughout Europe its genetic test for Androgenetic Alopecia, which the company said is the most common cause of hair loss in both men and women. The company noted that it has recently struck distribution agreements for the HairDX test in Italy and Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: system to track intron gains and losses, role of RUNX during mitosis, and more.

French officials release a report and move to strength safety measures for clinical trials, ScienceInsider reports.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.

Researchers trace the deaths of a pair of newborn siblings to a mutation in their LIPT1 genes through whole-exome sequencing, Stat News reports.